Affordable Access

A clinical comparative study of ofloxacin and pivampicillin in acute exacerbations of chronic bronchitis.

Authors
Type
Published Article
Journal
The Journal of antimicrobial chemotherapy
Publication Date
Volume
22 Suppl C
Pages
139–142
Identifiers
PMID: 3182456
Source
Medline

Abstract

A controlled clinical study employing a double-blind, double-dummy technique was carried out on 84 patients with purulent exacerbations of chronic bronchitis. Ofloxacin (200 mg x 2 daily) and pivampicillin (700 mg x 3 daily), were compared for efficacy, safety, and adverse reactions. Both regimens had high bacteriological elimination rates (94.1, 97.2%) and clinical cure rates (97.4, 97.6%). However, there were fewer adverse reactions and a greater patient acceptance in the ofloxacin treated group.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments